Pfizer's gene therapy for hemophilia A significantly cut the number of annual bleeding episodes in patients with the rare disorder in a late-stage study and performed better than the current ...

Results showed study participants with moderate/severe hemophilia had worse joint status, lower pressure pain thresholds and poorer health-related quality of life than those with mild hemophilia ...

Thrombocytopenia and hemophilia are two conditions that can affect the body’s ability to form blood clots. Although they have similar symptoms, they have different causes and treatments.

Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. Treatment focuses on managing bleeding episode symptoms with clotting factor replacement therapy ...